(S)-2-Ethoxy-4-(2-((3-Methyl-1-(2-(Piperidin-1-Yl)Phenyl)Butyl)Amino)-2-Oxoethyl)Benzoic Acid; Prandin,Gluconorm,Novonorm; 2-Ethoxy-4-[2-[[(1S)-3-Methyl-1-[2-(1-Piperidinyl)Phenyl]Butyl]Amino]-2-Oxoethyl]Benzoic Acid; (S)-(+)-2-Ethoxy-4-[[[N-[1-(2-Piperidinophenyl)-3-Methylbutyl]Amino]Carbonyl]Methyl]Benzoic Acid; Benzoic Acid, 2-Ethoxy-4-(2-((3-Methyl-1-(2-(1-Piperidinyl)Phenyl)Butyl)Amino)- 2-Oxoethyl)-, (S)-; Prandin, 2-Ethoxy-4-[2-[[(1S)-3-Methyl-1-[2-(1-Piperidinyl)Butyl]Amino]-2-Oxoethyl]-Benzoic Acid, Ag-Ee-623, Novonorm,; S(+)-2-Ethoxy-4-(2-Oxo-2-((Alpha-Isobutyl-2-Piperidinobenzyl)Amino)Ethyl)Benzoesure

Brief Introduction

Repaglinide is a diabetic drug, and is a non sulfonylurea type insulin releasing agent. Clinically, it is mainly used for patients with type 2 diabetes mellitus (non-insulin-dependent) who have diet control, weight reduction and exercise control which can not effectively control hyperglycemia.

Suppliers

View More Vendors (2） >

Hubei Yitai Pharmaceutical Co.,Ltd.

Pharm Grade

10kg

BOTTLE

Zhejiang Hisoar Pharmaceutical Co.,Ltd.

USP/EP/CP

Pharm Grade

25kg

Fibre Drum

Deflazacort

CAS:14484-47-0

Molecular Formula:C25H31NO6

Alias

More Information

Azacort; Calcort; Oxazacort; Flantadin; Emflaza; Cortax; Deflan; Unii-Kr5Yz6Ae4B; Dezacor; Lantadin; 2-((6Ar,6Bs,7S,8As,8Bs,11Ar,12As,12Bs)-7-Hydroxy-6A,8A,10-Trimethyl-4-Oxo-1,2,4,6A,6B,7,8,8A,11A,12,12A,12B-Dodecahydro-8Bh-Naphtho[2',1':4,5]Indeno[1,2-D]Oxazol-8B-Yl)-2-Oxoethyl Acetate; Deflazacortum; Decortil; Deflanil

Brief Introduction

Deflazacort is the third generation glucocorticoid, which has the effects of anti-inflammatory, anti allergic and increasing gluconeogenesis. It is used for primary or secondary adrenocortical dysfunction, rheumatism, collagen diseases, hematopoietic system diseases, ulcerative colitis, idiopathic nephrotic syndrome, hematopoietic system malignant tumor, allergic and allergic diseases, and combined with anti tuberculosis drugs in the treatment of fulminant and disseminated pulmonary tuberculosis.

Suppliers

View More Vendors (2） >

Hunan Yuxin Pharmaceutical Co., Ltd.

99%

Pharm Grade

25kg

Fibre Drum

Junye Pharmaceutical Co., Ltd

≥99.0%

Pharm Grade

25kg

Fibre Drum

Sacubitril

CAS:149709-62-6

Molecular Formula:C24H29NO5

Alias

More Information

Entresto (Trade Name, With Valsartan Sodium); 4-[[(2S,4R)-5-Ethoxy-4-Methyl-5-Oxo-1-(4-Phenylphenyl)Pentan-2-Yl]Amino]-4-Oxobutanoic Acid; Ahu-377; 4-(((2S,4R)-1-([1,1'-Biphenyl]-4-Yl)-5-Ethoxy-4-Methyl-5-Oxopentan-2-Yl)Amino)-4-Oxobutanoic Acid; 4-(((2R,4R)-1-([1,1'-Biphenyl]-4-Yl)-5-Ethoxy-4-Methyl-5-Oxopentan-2-Yl)Amino)-4-Oxobutanoic Acid; (2R,4S)-5-(Biphenyl-4-Yl)-4-[(3-Carboxypropionyl)Amino]-2-Methylpentanoic Acid Ethyl Ester; (2R,4S)-5-([1,1'-Biphenyl]-4-Yl)-4-(3-Carboxypropanamido)-2-Methylpentanoic Acid; Ahu-377,149709-62-6; Ahu-37; Ahu377; Ahu 377

Brief Introduction

Sacubitril (INN developmental code name AHU-377) is an antihypertensive drug used in combination with valsartan. The combination drug valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. It was approved under the FDA's priority review process for use in heart failure on July 7, 2015.

Suppliers

View More Vendors (2） >

Liaoyuan Silver Eagle Pharmaceutical Co., Ltd.

Pharm Grade

25kg

Fibre Drum

Shandong Joyochem,Co.,Ltd.

≥99%

Dutasteride

CAS:164656-23-9

Molecular Formula:C27H30F6N2O2

Alias

More Information

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(Trifluoromethyl)Phenyl]-9a,11a-Dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-Dodecahydroindeno[5,4-f]Quinoline-1-Carboxamide; (5Alpha,17beta)-N-(2,5-Bis(Trifluoromethyl)Phenyl)-3-oxo-4-Azaandrost-1-ene-17-Carboxamide; Alpha,Alpha,Alpha,Alpha',Alpha',Alpha'-Hexafluoro-3-oxo-4-aza-5Alpha-Androst-1-ene-17beta-Carboxy-2',5'-Xylidide; Avodart; Duagen

Brief Introduction

Dutasteride is a new 5 α Dual inhibitor of reductase, used in patients with moderate and severe symptoms of benign prostatic hyperplasia

Suppliers

View More Vendors (2） >

Hubei Gedian Humanwell Pharmaceutical Co., Ltd.